Memorial Sloan Kettering Cancer Center tightens conflict of interest rules after scandalsBMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l1762 (Published 11 April 2019) Cite this as: BMJ 2019;365:l1762
- Owen Dyer
- Montreal, Canada
One of America’s most famous hospitals, Memorial Sloan Kettering Cancer Center (MSK) in New York, will impose tight new rules on the corporate ties of doctors and executives after six months in which troubling conflicts of interest brought the institution a string of bad headlines.
An independent review by the law firm Debevoise and Plimpton found “a number of instances of serious noncompliance with MSK’s conflict of interest policies,” and concluded that plans to manage executive conflicts of interest were not implemented “because it was felt to be unnecessary.”
The hospital’s troubles began last September when its physician-in-chief José Baselga became the subject of a joint report by the New York Times and ProPublica, alleging that he had published dozens of …